189 related articles for article (PubMed ID: 27328457)
1. Measurement of residual platelet thrombogenicity under arterial shear conditions in cerebrovascular disease patients receiving antiplatelet therapy.
Yamazaki M; Ohnishi T; Hosokawa K; Yamaguchi K; Yoneyama T; Kawashima A; Okada Y; Kitagawa K; Uchiyama S
J Thromb Haemost; 2016 Sep; 14(9):1788-97. PubMed ID: 27328457
[TBL] [Abstract][Full Text] [Related]
2. Analysing responses to aspirin and clopidogrel by measuring platelet thrombus formation under arterial flow conditions.
Hosokawa K; Ohnishi T; Sameshima H; Miura N; Ito T; Koide T; Maruyama I
Thromb Haemost; 2013 Jan; 109(1):102-11. PubMed ID: 23179055
[TBL] [Abstract][Full Text] [Related]
3. Assessment of platelet-derived thrombogenicity with the total thrombus-formation analysis system in coronary artery disease patients receiving antiplatelet therapy.
Arima Y; Kaikita K; Ishii M; Ito M; Sueta D; Oimatsu Y; Sakamoto K; Tsujita K; Kojima S; Nakagawa K; Hokimoto S; Ogawa H
J Thromb Haemost; 2016 Apr; 14(4):850-9. PubMed ID: 26773298
[TBL] [Abstract][Full Text] [Related]
4. [Platelet responsiveness to clopidogrel in patients with coronary syndrome. Comparison of platelet aggregation induced by ADP and flow cytometric analysis of intraplatelet VASP phosphorylation].
Morel O; Viellard C; Faure A; Jesel L; Ohlmann P; Desprez D; Chauvin M; Roul G; Grunebaum L; Bareiss P
Ann Cardiol Angeiol (Paris); 2007 Jan; 56(1):21-9. PubMed ID: 17343035
[TBL] [Abstract][Full Text] [Related]
5. Soluble P-selectin level correlates with acetylsalicylic acid but not with clopidogrel response in patients with stable coronary artery disease after a percutaneous coronary intervention.
Kaufmann J; Wellnhofer E; Kappert K; Urban D; Meyborg H; Hauptmann T; Müller A; Meixner M; Graf K; Fleck E; Stawowy P
Coron Artery Dis; 2013 Jun; 24(4):312-20. PubMed ID: 23549485
[TBL] [Abstract][Full Text] [Related]
6. Response to antiplatelet therapy is independent of endogenous thrombin generation potential.
Gremmel T; Panzer S; Steiner S; Seidinger D; Koppensteiner R; Pabinger I; Kopp CW; Ay C
Thromb Res; 2013 Jul; 132(1):e24-30. PubMed ID: 23623170
[TBL] [Abstract][Full Text] [Related]
7. Evaluation of the role of the new INNOVANCE PFA P2Y test cartridge in detection of clopidogrel resistance.
Tsantes A; Ikonomidis I; Papadakis I; Kottaridi C; Tsante A; Kalamara E; Kardoulaki A; Kopterides P; Kapsimali V; Karakitsos P; Lekakis J; Travlou A
Platelets; 2012; 23(6):481-9. PubMed ID: 22646492
[TBL] [Abstract][Full Text] [Related]
8. Clopidogrel but not aspirin reduces P-selectin expression and formation of platelet-leukocyte aggregates in patients with atherosclerotic vascular disease.
Klinkhardt U; Bauersachs R; Adams J; Graff J; Lindhoff-Last E; Harder S
Clin Pharmacol Ther; 2003 Mar; 73(3):232-41. PubMed ID: 12621388
[TBL] [Abstract][Full Text] [Related]
9. PlaCor PRT measurement of shear-activated platelet aggregate formation in stable patients treated with single and dual antiplatelet therapy.
Godino C; Pavon AG; Mangieri A; Viani GM; Galaverna S; Spartera M; Chieffo A; Cappelletti A; Margonato A; Colombo A
Platelets; 2014; 25(5):337-42. PubMed ID: 23971989
[TBL] [Abstract][Full Text] [Related]
10. Relationships between optical aggregometry (type born) and flow cytometry in evaluating ADP-induced platelet activation.
Sbrana S; Della Pina F; Rizza A; Buffa M; De Filippis R; Gianetti J; Clerico A
Cytometry B Clin Cytom; 2008 Jan; 74(1):30-9. PubMed ID: 17630652
[TBL] [Abstract][Full Text] [Related]
11. The formation of monocyte-platelet aggregates is independent of on-treatment residual agonists'-inducible platelet reactivity.
Gremmel T; Kopp CW; Seidinger D; Giurgea GA; Koppensteiner R; Steiner S; Panzer S
Atherosclerosis; 2009 Dec; 207(2):608-13. PubMed ID: 19616779
[TBL] [Abstract][Full Text] [Related]
12. Comparison of a new P2Y12 receptor specific platelet aggregation test with other laboratory methods in stroke patients on clopidogrel monotherapy.
Bagoly Z; Sarkady F; Magyar T; Kappelmayer J; Pongrácz E; Csiba L; Muszbek L
PLoS One; 2013; 8(7):e69417. PubMed ID: 23844259
[TBL] [Abstract][Full Text] [Related]
13. The significance of vasodilator-stimulated phosphoprotein for risk stratification of stent thrombosis.
Blindt R; Stellbrink K; de Taeye A; Müller R; Kiefer P; Yagmur E; Weber C; Kelm M; Hoffmann R
Thromb Haemost; 2007 Dec; 98(6):1329-34. PubMed ID: 18064332
[TBL] [Abstract][Full Text] [Related]
14. Lack of association between the 807 C/T polymorphism of glycoprotein Ia gene and post-treatment platelet reactivity after aspirin and clopidogrel in patients with acute coronary syndrome.
Cuisset T; Frere C; Quilici J; Morange PE; Saut N; Romero-Barra M; Camoin L; Lambert M; Juhan-Vague I; Bonnet JL; Alessi MC
Thromb Haemost; 2007 Feb; 97(2):212-7. PubMed ID: 17264949
[TBL] [Abstract][Full Text] [Related]
15. A microchip flow-chamber system for quantitative assessment of the platelet thrombus formation process.
Hosokawa K; Ohnishi T; Fukasawa M; Kondo T; Sameshima H; Koide T; Tanaka KA; Maruyama I
Microvasc Res; 2012 Mar; 83(2):154-61. PubMed ID: 22166857
[TBL] [Abstract][Full Text] [Related]
16. A comparison of the antiplatelet effects of prasugrel and high-dose clopidogrel as assessed by VASP-phosphorylation and light transmission aggregometry.
Jakubowski JA; Payne CD; Li YG; Farid NA; Brandt JT; Small DS; Salazar DE; Winters KJ
Thromb Haemost; 2008 Jan; 99(1):215-22. PubMed ID: 18217157
[TBL] [Abstract][Full Text] [Related]
17. Comparison of platelet P2Y(12) ADP receptor-mediated pathway inhibition in triple versus dual antiplatelet therapy as assessed by VASP-phosphorylation in Japanese patients undergoing coronary stenting.
Fu Q; Yokoyama N; Takada K; Ishikawa S; Isshiki T
Int Heart J; 2010; 51(5):303-7. PubMed ID: 20966600
[TBL] [Abstract][Full Text] [Related]
18. Dynamic platelet adhesion in patients with an acute coronary syndrome: The effect of antiplatelet therapy.
Tsoumani ME; Tatsidou PT; Ntalas IV; Goudevenos JA; Tselepis AD
Platelets; 2016 Dec; 27(8):812-820. PubMed ID: 27337147
[TBL] [Abstract][Full Text] [Related]
19. Advanced age and high-residual platelet reactivity in patients receiving dual antiplatelet therapy with clopidogrel or ticagrelor.
Verdoia M; Pergolini P; Rolla R; Nardin M; Schaffer A; Barbieri L; Marino P; Bellomo G; Suryapranata H; De Luca G
J Thromb Haemost; 2016 Jan; 14(1):57-64. PubMed ID: 26512550
[TBL] [Abstract][Full Text] [Related]
20. Clinical utility of remote platelet function measurement using P-selectin: assessment of aspirin, clopidogrel, and prasugrel and bleeding disorders.
Bath PM; May J; Heptinstall S
Platelets; 2018 Jul; 29(5):425-430. PubMed ID: 29667460
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]